One-carbon metabolism markers are associated with cardiometabolic risk factors

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

One-carbon metabolism markers are associated with cardiometabolic risk factors. / Lind, Mads Vendelbo; Lauritzen, Lotte; Vestergaard, Henrik; Hansen, Torben; Pedersen, Oluf Borbye; Kristensen, Mette Bredal; Ross, Alistair B.

In: Nutrition, Metabolism & Cardiovascular Diseases, Vol. 28, No. 4, 2018, p. 402-410.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lind, MV, Lauritzen, L, Vestergaard, H, Hansen, T, Pedersen, OB, Kristensen, MB & Ross, AB 2018, 'One-carbon metabolism markers are associated with cardiometabolic risk factors', Nutrition, Metabolism & Cardiovascular Diseases, vol. 28, no. 4, pp. 402-410. https://doi.org/10.1016/j.numecd.2018.01.005

APA

Lind, M. V., Lauritzen, L., Vestergaard, H., Hansen, T., Pedersen, O. B., Kristensen, M. B., & Ross, A. B. (2018). One-carbon metabolism markers are associated with cardiometabolic risk factors. Nutrition, Metabolism & Cardiovascular Diseases, 28(4), 402-410. https://doi.org/10.1016/j.numecd.2018.01.005

Vancouver

Lind MV, Lauritzen L, Vestergaard H, Hansen T, Pedersen OB, Kristensen MB et al. One-carbon metabolism markers are associated with cardiometabolic risk factors. Nutrition, Metabolism & Cardiovascular Diseases. 2018;28(4):402-410. https://doi.org/10.1016/j.numecd.2018.01.005

Author

Lind, Mads Vendelbo ; Lauritzen, Lotte ; Vestergaard, Henrik ; Hansen, Torben ; Pedersen, Oluf Borbye ; Kristensen, Mette Bredal ; Ross, Alistair B. / One-carbon metabolism markers are associated with cardiometabolic risk factors. In: Nutrition, Metabolism & Cardiovascular Diseases. 2018 ; Vol. 28, No. 4. pp. 402-410.

Bibtex

@article{e78a6a56be1b47eeba9f77306b54da71,
title = "One-carbon metabolism markers are associated with cardiometabolic risk factors",
abstract = "BACKGROUND AND AIMS: Alterations to one-carbon metabolism, especially elevated plasma homocysteine (Hcy), have been suggested to be both a cause and a consequence of the metabolic syndrome (MS). A deeper understanding of the role of other one-carbon metabolites in MS, including s-adenosylmethionine (SAM), s-adenosylhomocysteine (SAH), and the methylation capacity index (SAM:SAH ratio) is required.METHODS AND RESULTS: 118 men and women with MS-risk factors were included in this cross-sectional study and cardiometabolic outcomes along with markers of one-carbon metabolism, including fasting plasma SAM, SAH, Hcy and vitamin B12concentrations, were analysed. Multiple linear regression models were also used to examine the association between plasma one-carbon metabolites and cardiometabolic health features. We found that fasting plasma concentrations of Hcy, SAM and SAH were all positively correlated with markers of adiposity, including BMI (increase in BMI per 1-SD increase in one-carbon metabolite: 0.92 kg/m295{\%} CI (0.28; 1.56), p = 0.005; 0.81 (0.15; 1.47), p = 0.02; 0.67 (-0.01; 1.36), p = 0.05, respectively). Hcy, but not SAM, SAH or SAM:SAH ratio was associated with BMI and body fat percentage after mutual adjustments. SAM concentrations were associated with higher fasting insulin (9.5{\%} 95{\%} CI (0.3; 19.5) per SD increase in SAM, p = 0.04), HOMA-IR (10.8{\%} (0.8; 21.9), p = 0.03) and TNF-α (11.8{\%} (5.0; 19.0), p < 0.001).CONCLUSION: We found little evidence for associations between SAM:SAH ratio and cardiometabolic variables, but higher plasma concentrations of SAM, SAH and Hcy are related to an overall higher risk of metabolic dysfunctions. The studies were registered at www.clinicaltrials.gov (NCT01719913 &NCT01731366).",
keywords = "Faculty of Science, Metabolic syndrome, Homocysteine, Insulin resistance, Obesity, Dyslipidaemia",
author = "Lind, {Mads Vendelbo} and Lotte Lauritzen and Henrik Vestergaard and Torben Hansen and Pedersen, {Oluf Borbye} and Kristensen, {Mette Bredal} and Ross, {Alistair B.}",
note = "CURIS 2018 NEXS 091",
year = "2018",
doi = "10.1016/j.numecd.2018.01.005",
language = "English",
volume = "28",
pages = "402--410",
journal = "Nutrition, Metabolism & Cardiovascular Diseases",
issn = "0939-4753",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - One-carbon metabolism markers are associated with cardiometabolic risk factors

AU - Lind, Mads Vendelbo

AU - Lauritzen, Lotte

AU - Vestergaard, Henrik

AU - Hansen, Torben

AU - Pedersen, Oluf Borbye

AU - Kristensen, Mette Bredal

AU - Ross, Alistair B.

N1 - CURIS 2018 NEXS 091

PY - 2018

Y1 - 2018

N2 - BACKGROUND AND AIMS: Alterations to one-carbon metabolism, especially elevated plasma homocysteine (Hcy), have been suggested to be both a cause and a consequence of the metabolic syndrome (MS). A deeper understanding of the role of other one-carbon metabolites in MS, including s-adenosylmethionine (SAM), s-adenosylhomocysteine (SAH), and the methylation capacity index (SAM:SAH ratio) is required.METHODS AND RESULTS: 118 men and women with MS-risk factors were included in this cross-sectional study and cardiometabolic outcomes along with markers of one-carbon metabolism, including fasting plasma SAM, SAH, Hcy and vitamin B12concentrations, were analysed. Multiple linear regression models were also used to examine the association between plasma one-carbon metabolites and cardiometabolic health features. We found that fasting plasma concentrations of Hcy, SAM and SAH were all positively correlated with markers of adiposity, including BMI (increase in BMI per 1-SD increase in one-carbon metabolite: 0.92 kg/m295% CI (0.28; 1.56), p = 0.005; 0.81 (0.15; 1.47), p = 0.02; 0.67 (-0.01; 1.36), p = 0.05, respectively). Hcy, but not SAM, SAH or SAM:SAH ratio was associated with BMI and body fat percentage after mutual adjustments. SAM concentrations were associated with higher fasting insulin (9.5% 95% CI (0.3; 19.5) per SD increase in SAM, p = 0.04), HOMA-IR (10.8% (0.8; 21.9), p = 0.03) and TNF-α (11.8% (5.0; 19.0), p < 0.001).CONCLUSION: We found little evidence for associations between SAM:SAH ratio and cardiometabolic variables, but higher plasma concentrations of SAM, SAH and Hcy are related to an overall higher risk of metabolic dysfunctions. The studies were registered at www.clinicaltrials.gov (NCT01719913 &NCT01731366).

AB - BACKGROUND AND AIMS: Alterations to one-carbon metabolism, especially elevated plasma homocysteine (Hcy), have been suggested to be both a cause and a consequence of the metabolic syndrome (MS). A deeper understanding of the role of other one-carbon metabolites in MS, including s-adenosylmethionine (SAM), s-adenosylhomocysteine (SAH), and the methylation capacity index (SAM:SAH ratio) is required.METHODS AND RESULTS: 118 men and women with MS-risk factors were included in this cross-sectional study and cardiometabolic outcomes along with markers of one-carbon metabolism, including fasting plasma SAM, SAH, Hcy and vitamin B12concentrations, were analysed. Multiple linear regression models were also used to examine the association between plasma one-carbon metabolites and cardiometabolic health features. We found that fasting plasma concentrations of Hcy, SAM and SAH were all positively correlated with markers of adiposity, including BMI (increase in BMI per 1-SD increase in one-carbon metabolite: 0.92 kg/m295% CI (0.28; 1.56), p = 0.005; 0.81 (0.15; 1.47), p = 0.02; 0.67 (-0.01; 1.36), p = 0.05, respectively). Hcy, but not SAM, SAH or SAM:SAH ratio was associated with BMI and body fat percentage after mutual adjustments. SAM concentrations were associated with higher fasting insulin (9.5% 95% CI (0.3; 19.5) per SD increase in SAM, p = 0.04), HOMA-IR (10.8% (0.8; 21.9), p = 0.03) and TNF-α (11.8% (5.0; 19.0), p < 0.001).CONCLUSION: We found little evidence for associations between SAM:SAH ratio and cardiometabolic variables, but higher plasma concentrations of SAM, SAH and Hcy are related to an overall higher risk of metabolic dysfunctions. The studies were registered at www.clinicaltrials.gov (NCT01719913 &NCT01731366).

KW - Faculty of Science

KW - Metabolic syndrome

KW - Homocysteine

KW - Insulin resistance

KW - Obesity

KW - Dyslipidaemia

U2 - 10.1016/j.numecd.2018.01.005

DO - 10.1016/j.numecd.2018.01.005

M3 - Journal article

C2 - 29499850

VL - 28

SP - 402

EP - 410

JO - Nutrition, Metabolism & Cardiovascular Diseases

JF - Nutrition, Metabolism & Cardiovascular Diseases

SN - 0939-4753

IS - 4

ER -

ID: 191897313